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Aims: Clinical guidelines for management of infants with fever but no evident focus of infection recom-
mend that those aged 1–3 months with a white cell count >15  109/l have a full septic screen and be
admitted for parenteral antibiotics. However, there is limited information about leucocyte changes fol-
lowing routine immunization, a common cause of fever. We investigated white cell counts shortly after
routine immunization in Ugandan infants under 3 months of age.
Methods: White cell counts were measured in 212 healthy infants following routine immunizations
(DTwP-HepB-Hib, oral polio and pneumococcal conjugate 7 vaccines) received prior to 3 months of age.
Results: Mean leucocyte counts increased from 9.03  109/l (95% confidence interval 8.59–9.47  109/l)
pre-immunizations to 16.46  109/l (15.4–17.52  109/l) at one-day post-immunizations at 6 weeks of
age, and 15.21  109/l (14.07–16.36  109/l) at one-day post-immunizations at 10 weeks of age. The leu-
cocytosis was primarily a neutrophilia, with neutrophil percentages one-day post-immunization of 49%
at 6 weeks of age and 46% at 10 weeks of age. White cell parameters returned to baseline by two-days
post-immunization. No participant received antibiotics when presenting with isolated fever post-
immunization and all remained well at follow-up.
Conclusions: In our study almost half the children <3 months old presenting with fever but no evident
focus of infection at one-day post-immunization met commonly used criteria for full septic screen and
admission for parenteral antibiotics, despite having no serious bacterial infection. These findings add
to the growing body of literature that questions the utility of white blood cell measurement in identifi-
cation of young infants at risk of serious bacterial infections, particularly in the context of recent
immunizations, and suggest that further exploration of the effect of different immunization regimes
on white cell counts is needed.
This observational work was nested within a clinical trial, registration number ISRCTN59683017.
 2018 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).
1. Introduction
Fever is one of the most common reasons for presentation of
children to medical professionals [1]. Children presenting with
no obvious focus for their infection can pose a diagnostic challenge
to clinicians. Algorithms exist to assist in the identification of chil-
dren who would benefit from investigation and admission to hos-
pital for treatment. These guidelines are particularly stringent for
febrile infants less than 3 months old, due to the increased risk
of occult serious bacterial infections [2]. Guidelines used in the
UK [3], and in adapted forms worldwide, advise that a full blood
count and partial septic screen should be performed on any infant
presenting with a fever >38 C without focus when less than 3
months of age, even if otherwise well-looking and regardless of
recent immunization history. Infants who have a white cell count
of >15  109/l are then admitted to hospital for a full septic screen,
including lumbar puncture, and parenteral antibiotics whilst cul-
ture results are pending (usually a minimum of 48 h).
https://doi.org/10.1016/j.vaccine.2018.03.026
0264-410X/ 2018 The Authors. Published by Elsevier Ltd.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
⇑ Corresponding author at: Department of Clinical Research, London School of
Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom.
E-mail addresses: sarah.prentice@nhs.net (S. Prentice), zephyrian.kamushaaga@
mrcuganda.org (Z. Kamushaaga), stephen.nash@lshtm.ac.uk (S.B. Nash), alison.
elliott@lshtm.ac.uk (A.M. Elliott), hazel.dockrell@lshtm.ac.uk (H.M. Dockrell),
stephen.cose@lsthm.ac.uk (S. Cose).
Vaccine 36 (2018) 2870–2875
Contents lists available at ScienceDirect
Vaccine
journal homepage: www.elsevier .com/locate /vaccine
Infants worldwide commonly receive a number of vaccinations
in the first few months of life, generally with multiple antigens
administered on one day [4]. These vaccines are highly immunos-
timulatory and the occurrence of fever >38 C following routine
vaccinations is well recognised. However, the effect on white cell
counts of the co-administration of multiple vaccine antigens, such
as those received during primary immunizations, is unknown.
Studies conducted in the 1980s in Finland and the USA in a small
number of older infants, showed an increase in white cell counts
post administration of the combined Diptheria-Tetanus-whole cell
Pertussis (DTwP) vaccination [5]. However, few similar studies
have been published looking at younger infants and using the
enhanced combination of vaccine antigens currently in use.
Lack of knowledge regarding alterations to white cell count
levels following routine immunization could severely impede clin-
ical decision making during the assessment of a feverish child. This
may have negative consequences for the child due to unnecessary
invasive investigations and antibiotic administration. This study
investigated alterations to white cell counts during the period
immediately following routine immunization, in the first 3 months
of life.
2. Methods
Post-immunization blood samples were collected from 212
Ugandan infants as part of a randomised controlled trial investigat-
ing the impact of BCG vaccination on the innate immune system
(described elsewhere [6]). In brief, infants were randomised to
receive BCG either at birth or at 6 weeks of age. All other routine
immunizations were given as per Ugandan national guidelines:
oral polio vaccine (OPV) at birth and pentavalent vaccine
(diptheria-tetanus-whole-cell pertussis/Haemophilus influenzae
B/Hepatitis B), OPV and pneumococcal vaccine (PCV10) at 6 weeks,
10 weeks and 14 weeks of age (hereafter referred to as ‘primary
immunization’). Infants were then randomly assigned to have
venous blood samples taken on two out of four possible time
points: (1) 5 days of age, (2) 6 weeks of age, 1 day following immu-
nization, (3) 6 weeks of age, 5 days following routine immuniza-
tion and (4) 10 weeks of age, 1 day following routine
immunization. In practice, blood samples were taken at a range
of times post-routine immunization, due to delayed attendance
at clinic for some participants. Infants with blood samples taken
more than 15 days following immunization were excluded from
analysis (n = 1). BCG vaccination in the delayed group was given
after blood sample 2 but prior to blood sample 3. However, upon
analysis, no significant impact of the different BCG schedules on
white blood cell count was shown and data were analysed
together.
Anthropometry, vital sign measurement and clinician review of
participants occurred at each appointment. Temperatures were
measured using a digital axillary thermometer, following current
best practice recommendations. Active follow-up of participants
occurred for the duration of the trial with open access to clinician
review and treatment, as well as weekly telephone follow-up, to
confirm health status.
Full blood counts were obtained using the automated Coulter
AcT 5diff CP (Beckman-Coulter, California, USA), from 0.5 ml of
venous blood drawn from the dorsum of the hands or feet into
an EDTA containing microtainer (Becton-Dickson).
Data were analysed using STATA version 14.1 (StataCorp, Texas,
USA) and graphs produced using Prism 6 (GraphPad Software, Inc.
California, USA). Results were normally distributed so means with
95% confidence intervals are reported, with Student’s t-test used
for comparison of means pre- and post-immunization. Changes
in mean values over time were analysed using a random effects
model to account for repeated measurements and including both
linear and quadratic terms for time to allow for a non-linear
relationship.
Ethical approval for the trial was obtained from the Uganda
Virus Research Institute Research and Ethics Committee (Ref:
GC/127/13/11/432), the Uganda National Council for Science and
Technology (Ref: HS 1524), The Office of the President of Uganda
and the London School of Hygiene & Tropical Medicine (Ref:
6545). The study was conducted according to the principles of
the Declaration of Helsinki. Written, informed consent of mothers
was obtained by trained study nurses prior to any procedures.
3. Results
Two hundred and twelve infants provided blood samples for
this study, 49% of them male. The background of the population
was East African, primarily of the Buganda tribe and participants
came from a mixture of urban, semi-urban and rural fishing com-
munities. No participant was severely malnourished at the time of
blood sample collection.
Average white cell counts were significantly increased at one-
day post receipt of primary immunizations at both 6 weeks of
age (16.46  109/l (95% confidence interval 15.40–17.52  109/l)
and 10 weeks of age (15.21  109/l (14.07–16.36  109/l)), com-
pared to pre-immunization values (9.03 109/l (8.59–9.47 109/l),
p-values for difference with post-immunization levels <0.0001, see
Table 1 and Fig. 1).
This rise in mean total leucocytes was short-lived, returning to
levels not significantly different from baseline by two days post-
immunization, but continuing to decline up to six-days post-
immunization (p < 0.0001) (Fig. 2). Although mean white cell
counts at one day post-immunization fell within the normal range
expected for age (5.0–19.5  109/l) [7], there was a wide range of
values (8.00–32.90  109/l at one-day post 6-week immunization
and 6.20–29.80  109/l at one day post 10-week immunization).
At both time-points an average of 22% of white cell counts mea-
sured fell outside of the normal range for age. At one day post-
immunization, on average 53% of measured white cell counts were
above the 15  109/l cut-off for further intervention when manag-
ing a febrile child <3 months old (Fig. 1).
The leucocytosis observed at one-day post immunization was
primarily a neutrophilia (Table 1 and Fig. 3). Little change occurred
to total lymphocyte levels, other than an expected increase with
age (see Fig. 3). As a result at one-day post-primary immunization,
the percentage of the white cell count made up by lymphocytes
dropped as the percentage accounted for by neutrophils increased
(Table 1 and Fig. 3). The average percentage of neutrophils was
above the normal range for age (up to 32% neutrophils [7]) at
one-day post-primary immunization at both 6 weeks of age
(49%) and 10 weeks of age (46%). Total monocyte and basophil
levels mimicked changes to neutrophils post-immunization,
though to a much smaller extent (Table 1). The reverse occurred
with eosinophils, with total eosinophils dropping at 1-day post-
immunization and rising by day 2. The changes to monocyte,
basophil and eosinophil count were only significant at the
6-week time-point. There was little change to the percentage of
monocytes, eosinophils and basophils by immunization status.
Linear regression analysis provided good evidence (p < 0.0001)
of a weak, positive association of temperature and white cell
counts, with each one degree Celsius increase in temperature asso-
ciated with a 0.04  109/l increase in white cell count (Fig. 4). Of all
children studied that presented with a fever >38 C when the blood
sample was taken, 5 out of 11 (45%) had a white cell count above
the currently recommended threshold for further investigation
and inpatient management with IV antibiotics. A further 17 moth-
ers reported that their children had been pyrexial prior to presen-
tation. Of these, 3 (18%) had white cell counts above 15  109/l. All
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children presenting with either fever >38 C or with parental
report of fever were clinically assessed as being well and treated
conservatively as outpatients without antibiotics. All remained
well at follow-up and no cases of serious bacterial infection
occurred. Eighty-five infants had white cell counts >15  109/l,
but were afebrile, with 28 of these having white cell counts above
the normal reference range for age.
These data provided no evidence that either BCG immunization
status or gender had any impact on results. There was also no evi-
dence of a difference in mean haemoglobin and platelet counts
comparing pre- and post-immunization levels, other than an
expected decrease in haemoglobin with increasing infant age
(see Table 1).
4. Discussion
This study shows a rapid and large increase in white cells, pri-
marily neutrophils, occurring in infants <3 months old immedi-
ately following primary immunizations. This increase is above
current guideline thresholds for further investigation and treat-
ment in nearly half of febrile infants studied and above the normal
white cell count range for age in more than a quarter of infants
studied. These infants all remained well during the post-
immunization period, in the absence of intervention, and mean
white cell counts returned to baseline by two-days post-
immunization. These infants therefore represent a group that
may cause diagnostic confusion and undergo unnecessary
Table 1
Blood count parameters in relation to primary immunizations CI: confidence interval.
Pre-immunizations 6 weeks of age 10 weeks of age
Mean age 10 days
(range 2–19 days)
1-day post-primary
immunizations
2-days post-primary
immunization
(mean 5.7 days)
1-day post-primary
immunization
2-days post primary
immunization
(mean 3.4 days)
n = 106 n = 81 n = 111 n = 70 n = 12
Total White Cell
Count  109/l (95% CI)
9.03 (8.59–9.47) 16.46 (15.40–17.52) 9.34 (8.84–9.84) 15.21 (14.07–16.36) 12.02 (9.51–14.52)
Subset Counts  109/l (95% CI)
Neutrophils 2.65 (2.42–2.88) 8.58 (7.64–9.52) 2.21 (2.02–2.41) 7.00 (6.36–7.64) 3.07 (1.94–4.20)
Lymphocytes 4.64 (4.40–4.87) 6.15 (5.78–6.51) 5.81 (5.48–6.14) 6.24 (5.73–6.76) 7.22 (5.80–8.64)
Monocytes 1.13 (1.04–1.22) 1.70 (1.55–1.85) 0.92 (0.85–0.99) 1.43 (1.27–1.58) 1.06 (0.74–1.38)
Eosinophils 0.35 (0.31–0.38) 0.14 (0.12–0.16) 0.27 (0.23–0.30) 0.33 (0.28–0.38) 0.46 (0.26–0.66)
Basophils 0.26 (0.22–0.31) 0.26 (0.23–0.29) 0.14 (0.12–0.15) 0.22 (0.19–0.25) 0.21 (0.15–0.27)
Percentage (95% CI)
Neutrophils 28.6 (27.08–30.12) 48.89 (46.98–50.80) 23.54 (22.12–24.97) 45.87 (43.93–47.81) 24.96 (19.54–30.37)
Lymphocytes 52.19 (50.36–54.03) 38.42 (36.58–40.27) 62.28 (60.68–63.88) 41.41 (39.42–43.39) 61.05 (54.72–67.37)
Monocytes 12.44 (11.79–13.09) 10.30 (9.77–10.82) 9.86 (9.33–10.38) 9.22 (8.71–9.73) 8.40 (7.08–9.72)
Eosinophils 3.96 (3.52–4.39) 0.88 (0.78–0.97) 2.92 (2.52–3.32) 2.17 (1.90–2.44) 3.94 (2.35–5.53)
Basophils 2.80 (2.38–3.21) 1.48 (1.39–1.58) 1.41 (1.33–1.49) 1.32 (1.22–1.43) 1.67 (1.35–1.99)
Haemoglobin g/dl (95% CI) 15.98 (15.57–16.38) 10.68 (10.39–10.96) 11.09 (10.87–11.31) 10.30 (10.07–10.54) 10.79 (10.24–11.34)
Platelet counts  109/l (95% CI) 362.10 (337.08–387.11) 524.52 (493.86–555.17) 575.62 (547.11–604.13) 443.26 (416.87–469.64) 520.42 (455.12–585.71)
Fig. 1. Total white cell counts by immunization status. Individual data points are represented by dots. Error bars display the 95% confidence interval.
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investigations and interventions if they present to a clinician feb-
rile, or if they have a blood test taken for an unrelated condition,
at one-day post-immunization. The development of new post-
immunization reference ranges could help to mitigate this. In the
absence of other data for our population, our study would suggest
a reference range of total leucocytes: 7.76–27.25  109/l, percent-
age neutrophils: 29%-65% (2.5–97.5th centiles [8]) as appropriate
for infants less than 3 months old, one-day following routine
immunizations.
This study’s strengths lie in its comparatively large study num-
bers, giving robust results, and the presence of blood samples from
a variety of time-points post-primary immunizations, allowing the
timing of changes in white cell counts post-primary immuniza-
tions to be investigated. The close follow-up of participants during
the post-immunization period provides reassuring evidence that
children with fevers and high white cell counts immediately
following immunization can remain well without further
intervention.
The study has a number of limitations. Firstly, it is a secondary
analysis conducted as part of a larger randomised controlled trial
that was not specifically designed to look at white cell counts in
post-immunization pyrexia. As a result, the number of febrile
infants in the study was limited. However, the correlation between
temperature and white cell count seen in our study suggests that
these results can be extrapolated to febrile infants more generally,
with higher white cell counts expected in those infants that have
post-immunization pyrexia. Supporting this theory, a study inves-
tigating serious bacterial infections in recently immunized infants
in the USA similarly showed an increase in white cell counts in
recently immunized febrile infants with no serious bacterial infec-
tion [9]. The finding of increased white cell counts in afebrile
infants post-immunization is also important, as nearly a quarter
of cases in our study fell outside the normal range. These cases
might cause diagnostic confusion if blood is sampled following
immunizations for another reason.
Another limitation of this study is that the time course of
changes to white cell counts post-immunizations could be exam-
ined only because some participants did not attend their
per-protocol appointments at the correct time (24 h or 5 days
post-immunizations). It may be argued that these participants rep-
resent a different sub-set of the population, for instance infants
who had fewer post-immunization symptoms, and may therefore
have falsely lower white cell counts than the population as a
whole. However, the time-course of white cell count changes fol-
lowed a logical pattern with average levels declining until day 7
post-immunization (which encompassed the per-protocol appoint-
ment day 5 post-immunizations) and mirrored the time-course of
changes to IL-6 and CRP that have been shown post-DTwP immu-
nization in another study [10]. Also, the timing of blood samples
used to obtain pre-immunization average white cell counts was
at an average of 10 days of post-natal age, rather than immediately
prior to the receipt of primary immunizations, due to the design
requirements of the parent trial. This comparison was deemed to
Fig. 2. White cell count by time post-immunizations. Individual data points are
represented by dots. The line represents results of the random effects regression
model.
Fig. 3. Total and percentage neutrophils and leucocytes by immunization status.
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be acceptable, however, as white cell counts are known to be high
at birth, falling to adult levels by approximately 2 weeks of age
[11]. Samples taken at an average of 10 days of post-natal age
would therefore be more likely to under-estimate the degree of
change in white cell counts following primary immunizations,
rather than falsely over-estimate it.
The generalizability of this study’s findings may be limited due
to its restricted study population and the choice of vaccine combi-
nation used for primary immunization. As the study was con-
ducted in Uganda, the ethnicity of infants was solely black
African. White cell counts in black Africans, however, tend to be
lower than in other ethnic groups [12–14]. It is therefore possible
that white cell count changes post-primary immunization would
be at least as marked, if not more, in other populations. Previous
studies conducted in white European and mixed American popula-
tions have also shown white cell count increases at one-day post-
immunization [5,9], though to a lesser extent than with the combi-
nation of vaccines used in this study.
The combination of vaccines used as primary immunizations is
not the same throughout the world and this may limit the global
applicability of these findings. Most primary immunization
regimes include components against diptheria, tetanus, pertussis,
Haemophilus influenzae type B and pneumococcus (as were
included in this study) [4]. However, the use of oral polio vaccine
has been replaced in high-income countries with an inactivated
vaccine [15], and immunization against hepatitis B is often only
given to those deemed at high risk. Additional vaccines, not used
in this study, such as meningococcal and rotavirus vaccine are also
commonplace in many other areas of the world. The differences in
vaccine components used may cause variations in the degree of
post-immunization leukocytosis. Of these, the replacement of
whole cell pertussis (used in this study and in many low income
countries as part of the 5-in-1 vaccine) with acellular pertussis
(used in many European and North American countries) may have
the most impact on post-immunization leukocytosis [10,16],
though a study into serious bacterial infections in the context of
post-immunization pyrexia used DTaP and also revealed a raised
white cell count post-immunizations [9]. A previous study con-
ducted in Gambian neonates [17] showed no increase in white cell
counts following oral polio and hepatitis B vaccination (as well as
BCG), suggesting that it was not these components of primary
immunizations that were responsible for post-immunization
leukocytosis (unpublished findings), and thus the discontinuation
of their use in high-income countries might not affect results.
The addition of further antigens/adjuvants/vaccines to the basic
vaccine combination used in this study may be hypothesized to
further increase immunostimulation and white cell counts, rather
than diminish them. Thus, the recommendations of this study
may be a conservative estimation of changes occurring in other
areas of the world. However, further studies in different settings
would be necessary for the development of a robust global refer-
ence range for post-immunization white cell counts. The timing
of primary immunizations also varies globally, which may affect
a child’s post-immunization white cell count response. However,
this study showed similar increases in white cell counts at 6 weeks
and 10 weeks of age, suggesting that small variations in immuniza-
tion timing are unlikely to affect overall responses.
This study adds to the current debate regarding the utility of
white cell counts in the assessment of children who present febrile
with no clear focus for infection. Since the introduction of immu-
nizations against Streptococcus pneumonia and Haemophilus
influenza, the incidence of serious bacterial infections in young feb-
rile infants has reduced [18]. Several studies have subsequently
found that a cut-off of 15  109/l white cells is neither sensitive
nor specific for the identification of serious bacterial infections in
febrile children [19–27]. Newer proposed algorithms for assess-
ment of fever with no focus have tended to relegate this parameter
in favour of other markers of infection, such as CRP and procalci-
tonin [28,29]. However, these new algorithms have not been
widely adopted at present. We suggest that, particularly in the con-
text of immunization within the previous 24 h, white cell count
should not be used as a discriminatory factor when deciding
whether to admit and treat children under the age of 3 months
old who present with fever and no source of infection. If the use
of white cell counts is continued, we suggest that policymakers
consider introducing either a higher white cell count threshold
for further investigation and management in an otherwise well
child <3 months old presenting one day post-immunizations, or a
provision for a 24-h observation period with repeat white cell
count, into the current guidelines for the treatment of febrile
infants. This would reduce harm to patients by avoiding unneces-
sary invasive procedures and antibiotics, and reduce the burden on
paediatric healthcare systems.
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